1112 related articles for article (PubMed ID: 16308421)
1. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin.
Shaw RJ; Lamia KA; Vasquez D; Koo SH; Bardeesy N; Depinho RA; Montminy M; Cantley LC
Science; 2005 Dec; 310(5754):1642-6. PubMed ID: 16308421
[TBL] [Abstract][Full Text] [Related]
2. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.
Foretz M; Hébrard S; Leclerc J; Zarrinpashneh E; Soty M; Mithieux G; Sakamoto K; Andreelli F; Viollet B
J Clin Invest; 2010 Jul; 120(7):2355-69. PubMed ID: 20577053
[TBL] [Abstract][Full Text] [Related]
3. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats.
Jiang SJ; Dong H; Li JB; Xu LJ; Zou X; Wang KF; Lu FE; Yi P
World J Gastroenterol; 2015 Jul; 21(25):7777-85. PubMed ID: 26167077
[TBL] [Abstract][Full Text] [Related]
4. Energy-sensing factors coactivator peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α) and AMP-activated protein kinase control expression of inflammatory mediators in liver: induction of interleukin 1 receptor antagonist.
Buler M; Aatsinki SM; Skoumal R; Komka Z; Tóth M; Kerkelä R; Georgiadi A; Kersten S; Hakkola J
J Biol Chem; 2012 Jan; 287(3):1847-60. PubMed ID: 22117073
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of LKB1 at serine 428 by protein kinase C-zeta is required for metformin-enhanced activation of the AMP-activated protein kinase in endothelial cells.
Xie Z; Dong Y; Scholz R; Neumann D; Zou MH
Circulation; 2008 Feb; 117(7):952-62. PubMed ID: 18250273
[TBL] [Abstract][Full Text] [Related]
6. LKB1: a sweet side to Peutz-Jeghers syndrome?
Carling D
Trends Mol Med; 2006 Apr; 12(4):144-7. PubMed ID: 16530014
[TBL] [Abstract][Full Text] [Related]
7. Convergence of IPMK and LKB1-AMPK signaling pathways on metformin action.
Bang S; Chen Y; Ahima RS; Kim SF
Mol Endocrinol; 2014 Jul; 28(7):1186-93. PubMed ID: 24877601
[TBL] [Abstract][Full Text] [Related]
8. Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells.
Kukidome D; Nishikawa T; Sonoda K; Imoto K; Fujisawa K; Yano M; Motoshima H; Taguchi T; Matsumura T; Araki E
Diabetes; 2006 Jan; 55(1):120-7. PubMed ID: 16380484
[TBL] [Abstract][Full Text] [Related]
9. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism.
Koo SH; Flechner L; Qi L; Zhang X; Screaton RA; Jeffries S; Hedrick S; Xu W; Boussouar F; Brindle P; Takemori H; Montminy M
Nature; 2005 Oct; 437(7062):1109-11. PubMed ID: 16148943
[TBL] [Abstract][Full Text] [Related]
10. [From cancer to diabetes treatment : the tumor suppressor LKB1 as a new pharmacological target].
Foretz M; Guigas B; Viollet B
Med Sci (Paris); 2006 Apr; 22(4):348-50. PubMed ID: 16597397
[No Abstract] [Full Text] [Related]
11. Thyroid hormone effects on LKB1, MO25, phospho-AMPK, phospho-CREB, and PGC-1alpha in rat muscle.
Branvold DJ; Allred DR; Beckstead DJ; Kim HJ; Fillmore N; Condon BM; Brown JD; Sudweeks SN; Thomson DM; Winder WW
J Appl Physiol (1985); 2008 Oct; 105(4):1218-27. PubMed ID: 18669938
[TBL] [Abstract][Full Text] [Related]
12. Berberine Inhibits Gluconeogenesis in Skeletal Muscles and Adipose Tissues in Streptozotocin-induced Diabetic Rats via LKB1-AMPK-TORC2 Signaling Pathway.
Xu XH; Hu Q; Zhou LS; Xu LJ; Zou X; Lu FE; Yi P
Curr Med Sci; 2020 Jun; 40(3):530-538. PubMed ID: 32681256
[TBL] [Abstract][Full Text] [Related]
13. The LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver.
Patel K; Foretz M; Marion A; Campbell DG; Gourlay R; Boudaba N; Tournier E; Titchenell P; Peggie M; Deak M; Wan M; Kaestner KH; Göransson O; Viollet B; Gray NS; Birnbaum MJ; Sutherland C; Sakamoto K
Nat Commun; 2014 Aug; 5():4535. PubMed ID: 25088745
[TBL] [Abstract][Full Text] [Related]
14. LKB1-AMPK signaling in muscle from obese insulin-resistant Zucker rats and effects of training.
Sriwijitkamol A; Ivy JL; Christ-Roberts C; DeFronzo RA; Mandarino LJ; Musi N
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E925-32. PubMed ID: 16352671
[TBL] [Abstract][Full Text] [Related]
15. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha.
Jäger S; Handschin C; St-Pierre J; Spiegelman BM
Proc Natl Acad Sci U S A; 2007 Jul; 104(29):12017-22. PubMed ID: 17609368
[TBL] [Abstract][Full Text] [Related]
16. Medicine. Cancer-suppressing enzyme adds a link to type 2 diabetes.
Marx J
Science; 2005 Nov; 310(5752):1259. PubMed ID: 16311305
[No Abstract] [Full Text] [Related]
17. Role of AMP-activated protein kinase in mechanism of metformin action.
Zhou G; Myers R; Li Y; Chen Y; Shen X; Fenyk-Melody J; Wu M; Ventre J; Doebber T; Fujii N; Musi N; Hirshman MF; Goodyear LJ; Moller DE
J Clin Invest; 2001 Oct; 108(8):1167-74. PubMed ID: 11602624
[TBL] [Abstract][Full Text] [Related]
18. Skeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves glucose homeostasis, and decreases TRB3.
Koh HJ; Arnolds DE; Fujii N; Tran TT; Rogers MJ; Jessen N; Li Y; Liew CW; Ho RC; Hirshman MF; Kulkarni RN; Kahn CR; Goodyear LJ
Mol Cell Biol; 2006 Nov; 26(22):8217-27. PubMed ID: 16966378
[TBL] [Abstract][Full Text] [Related]
19. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP.
Kim YD; Park KG; Lee YS; Park YY; Kim DK; Nedumaran B; Jang WG; Cho WJ; Ha J; Lee IK; Lee CH; Choi HS
Diabetes; 2008 Feb; 57(2):306-14. PubMed ID: 17909097
[TBL] [Abstract][Full Text] [Related]
20. CITED2 links hormonal signaling to PGC-1α acetylation in the regulation of gluconeogenesis.
Sakai M; Matsumoto M; Tujimura T; Yongheng C; Noguchi T; Inagaki K; Inoue H; Hosooka T; Takazawa K; Kido Y; Yasuda K; Hiramatsu R; Matsuki Y; Kasuga M
Nat Med; 2012 Mar; 18(4):612-7. PubMed ID: 22426420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
